TEM raises its 2026 revenue outlook as oncology testing, data demand and FDA-linked pricing gains support growth and cash ...
Stargazers keen to see the partial eclipse of the sun will get help from the experts to watch it safely across the South West ...
Labcorp’s CDx is designed to detect BRAF V600E and V600K melanoma mutations to determine which patients are eligible for BRAF ...
Labcorp's FDA-approved PGDx elio® tissue complete CDx helps identify advanced melanoma patients with certain BRAF variants eligible for BRAF and BRAF/MEK inhibitor ...
People in the South West of England are likely to see the most coverage in England, while people in parts of Greenland, Iceland and northern Spain will experience a total eclipse. The celestial event ...
The news isn’t just “investing more”—it’s deepening Nvidia’s role in the AI buildout so customers can finance power/data-center spend that ultimately buys Nvidia GPUs. The SpaceX Vera Rubin commitment ...
Your counter will reset on the first day of next month.
Barzolvolimab Phase 3 chronic spontaneous urticaria studies (EMBARQ-CSU 1 and 2) ongoing, topline data expected in Sept/Oct 2026; BLA submission ...
CellCarta, a global CRO laboratory supporting the biopharmaceutical industry, today announced a strategic collaboration with Tempus AI, Inc. . Under the agreement, CellCarta will include Tempus in its ...
As part of its USA 250 initiative, USA Today recently unveiled its top 10 greatest college athletes to ever play in Vermont, ...
Guardian Capital LP has introduced a new actively managed fund that uses AI to select stocks that generate meaningful revenue ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results